A small bispecific antibody construct expressed as a functional single-chain molecule with high tumor cell cytotoxicity.

M Mack, G Riethmüller, P Kufer - Proceedings of the …, 1995 - National Acad Sciences
Construction of a bispecific single-chain antibody derivative is described that consists of two
different single-chain Fv fragments joined through a Gly-Ser linker. One specificity of the two …

Regression of advanced ovarian carcinoma by Intraperitoneal treatment with autologous TLymphocytes retargeted by a bispecific monoclonal antibody

S Canevari, G Stoter, F Arienti, G Bolis… - JNCI: Journal of the …, 1995 - academic.oup.com
Background: The high frequency of relapse after induction chemotherapy of advanced
ovarian carcinoma calls for new therapeutic approaches. Lysis of ovarian carcinoma cells …

Phase Ia/Ib trial of bispecific antibody MDX-210 in patients with advanced breast or ovarian cancer that overexpresses the proto-oncogene HER-2/neu.

FH Valone, PA Kaufman, PM Guyre… - Journal of clinical …, 1995 - ascopubs.org
PURPOSE MDX-210 is a bispecific antibody that binds simultaneously to type I Fc receptors
for immunoglobulin G (IgG)(Fc gamma RI) and to the HER-2/neu oncogene protein product …

Tumor therapy by immune recruitment with bispecific antibodies.

C Renner, M Pfreundschuh - Immunological reviews, 1995 - europepmc.org
Many strategies for experimental immunotherapy of cancers aim at inducing and expanding
tumor-specific cytotoxic T-lymphocytes. One of the most promising approaches uses …

Synergistic roles of granzymes A and B in mediating target cell death by rat basophilic leukemia mast cell tumors also expressing cytolysin/perforin.

H Nakajima, HL Park, PA Henkart - The Journal of experimental …, 1995 - rupress.org
We have studied the cytotoxic activity of rat basophilic leukemia (RBL) cells transfected with
cDNAs for the cytotoxic T lymphocyte (CTL) granule components, cytolysin (perforin) …

Bispecific antibody-mediated target cell-specific costimulation of resting T cells via CD5 and CD28

BJ Kroesen, A Bakker, RAW van Lier, HT The, L de Leij - Cancer research, 1995 - AACR
Induction of T-cell activation requires multiple signals provided by cell surface receptor
interactions and/or cytokines. T-cell stimulation via the T-cell receptor/CD3 complex provides …

Performance of CD3xCD19 bispecific monoclonal antibodies in B cell malignancy

IA Haagen - Leukemia & Lymphoma, 1995 - Taylor & Francis
Bispecific monoclonal antibodies, with a dual specificity for tumor associated antigens on
target cells and for surface markers on immune effector cells, have been shown (in vitro) to …

[PDF][PDF] Tumour targetting of the anti-ovarian carcinoma X anti-CD3/TCR bispesific monoclonal antibody OC/TR and its parental MOv18 antibody in experimental …

OC Boerman, JG Tibben, LFAG Massuger… - 1995 - repository.ubn.ru.nl
The anti-tumour x anli-T-cell bispecific monoclonal antibody (hiMAh) ОС/TR is a biologically
produced hiMAb combining the anti-ovarian carcinoma activity of lhe MOvlH MAb with anti …

Monoclonal antibodies in diagnostic immunoassays

DB Cook, CH Self - Monoclonal antibodies, 1995 - books.google.com
1 Gruber & Durham (1896), Widal & Sicard (1896) and Kraus (1897) published some of the
earliest immunological diagnostic techniques. Paul Ehrlich, however, has been described as …

Cytotoxic lymphocyte‐mediated immunotherapy

MJ Smyth, MH Kershaw - Australian and New Zealand Journal …, 1995 - Wiley Online Library
Cytotoxic CD8+ T cells and NK cells play a role in the elimination of some viruses, graft
rejection, antitumour responses, immuno regulation and some autoimmune diseases. The …